Rapid Progressive Interstitial Lung Diseases
1 clinical trials · Condition
◉ Watch Rapid Progressive Interstitial Lung Diseases
| Record | Firm | Date |
|---|---|---|
| The Efficacy and Safety of Tocilizumab for Severe RP-ILD Secondary to Systemic Diseases (NCT05181397) | Peking Union Medical College Hospital | 2021-02-22 |
Track Rapid Progressive Interstitial Lung Diseases automatically
Every clearance here is in the API, with alerts when new ones post.